The Retinal Degeneration Gene Panel Test is a sophisticated diagnostic tool designed to identify genetic mutations associated with various forms of retinal degeneration, including age-related macular degeneration, retinitis pigmentosa, and Leber congenital amaurosis among others. By analyzing a comprehensive panel of genes known to be linked with these conditions, the test provides valuable insights that can aid in early diagnosis, management, and treatment planning for affected individuals.
Conducted at DNA Labs UAE, a leading facility renowned for its advanced genetic testing capabilities, the test harnesses cutting-edge sequencing technologies to accurately detect mutations that could lead to retinal degeneration. This is particularly crucial for individuals with a family history of retinal diseases, as it can offer predictive information and help in understanding the risk of developing such conditions.
The cost of the Retinal Degeneration Gene Panel Test at DNA Labs UAE is set at 7200 AED. While the price may seem significant, the comprehensive nature of the test, combined with the expertise and technological infrastructure of DNA Labs UAE, ensures a high level of accuracy and reliability in the results. For patients and families dealing with the challenges of retinal degeneration, this test represents a valuable investment in their health and well-being, providing essential information that can guide treatment decisions and potentially improve quality of life.
The Glucose-6-Phosphate Dehydrogenase (G6PD) Full-Length Gene Sequence Analysis Test is a comprehensive diagnostic procedure aimed at identifying mutations within the G6PD gene. This gene plays a crucial role in the normal processing of carbohydrates and is essential for the proper functioning of red blood cells. Mutations in the G6PD gene can lead to G6PD deficiency, a genetic disorder that can cause hemolytic anemia, jaundice, and other health issues upon exposure to certain medications, foods, or infections.
Performed at DNA Labs UAE, this test involves analyzing the entire length of the G6PD gene to detect any genetic variations that might lead to the disorder. This detailed analysis is crucial for accurate diagnosis, allowing for personalized treatment plans and management strategies for affected individuals. The test cost is 9010 AED, reflecting the intricate process and the sophisticated technology employed to ensure precise results. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic factors contributing to G6PD deficiency, facilitating informed decision-making and optimal care.
The Oncomine Myeloid Panel MDSMPNAMLCMLCMMLJMML Test, available at DNA Labs UAE, is a comprehensive genetic test designed to aid in the diagnosis and management of various myeloid disorders. This test focuses on a range of myeloid conditions, including Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML), and Juvenile Myelomonocytic Leukemia (JMML). By analyzing specific genetic mutations and alterations associated with these conditions, the panel provides valuable insights that can guide treatment decisions and prognosis assessments.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test employs cutting-edge sequencing technologies to ensure high accuracy and reliability of results. The cost of the Oncomine Myeloid Panel MDSMPNAMLCMLCMMLJMML Test is 7500 AED, reflecting the comprehensive nature of the analysis and the advanced technology used.
This test represents a crucial tool in the personalized medicine approach for myeloid disorders, offering patients and healthcare providers a detailed genetic profile that can influence treatment strategies and ultimately improve patient outcomes.
The “Pre-Implantation Genetic Disorder (PGD) Single Embryo with Maternal DNA Contamination Check Test” is a sophisticated diagnostic procedure offered by DNA Labs UAE, designed to screen embryos for genetic disorders before implantation. This test is particularly crucial for couples undergoing in vitro fertilization (IVF) who want to ensure their future child is free from specific genetic conditions. The inclusion of a maternal DNA contamination check is a critical component, as it ensures the accuracy of the test by distinguishing between the DNA of the embryo and potential contaminants from the mother’s genetic material. This step is essential for providing clear and uncontaminated genetic results of the embryo itself.
The cost of this comprehensive test is set at 7500 AED. This investment covers the meticulous process of extracting a single cell from an embryo, analyzing its genetic makeup, and checking for any maternal DNA contamination to ensure the reliability of the test results. By opting for this test, prospective parents can make informed decisions about embryo implantation, significantly increasing their chances of a healthy pregnancy and reducing the risk of passing on hereditary genetic disorders. DNA Labs UAE, by offering this advanced genetic screening test, plays a pivotal role in the realm of reproductive health and genetic diagnostics, providing families with hope and options for a healthy future.
Clinical Exome Sequencing for Couples is a comprehensive genetic test offered by DNA Labs UAE, designed to analyze the exomes – the parts of the genome that code for proteins, which constitute about 1-2% of the human genome but contain about 85% of known genetic disease causes. This test is particularly valuable for couples who are planning to start a family and wish to understand their risk of passing on genetic disorders to their offspring.
The process involves collecting DNA samples from both partners, usually through a simple blood draw. The samples are then sequenced to identify any genetic variations that could potentially lead to health issues in their children. By examining the exomes of both parents, the test can provide insights into a wide range of inherited conditions, enabling couples to make informed decisions about their reproductive options.
The test is priced at 7500 AED, reflecting the extensive analysis and personalized consultation that accompanies the results. DNA Labs UAE, known for its cutting-edge genetic testing services, employs state-of-the-art technology and adheres to strict confidentiality and ethical standards, ensuring that couples receive accurate, useful, and private genetic counseling based on their test results. This service is an investment in the health and well-being of future generations, offering peace of mind and empowering couples with critical information about their genetic health.
The Oncomine Comprehensive Myeloid Panel Test is a cutting-edge diagnostic tool designed to provide a comprehensive genetic analysis of myeloid cancers. This innovative test, available at DNA Labs UAE, leverages next-generation sequencing technology to examine a wide array of genetic mutations associated with various myeloid malignancies, including leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. By analyzing the genetic blueprint of a patient’s cancer, the Oncomine Comprehensive Myeloid Panel Test helps healthcare professionals to tailor personalized treatment plans, predict disease progression, and identify potential therapeutic targets.
Priced at 6400 AED, this test represents a significant investment in the precision and personalization of cancer care. Despite the cost, the value derived from the detailed insights into the genetic underpinnings of an individual’s cancer can be pivotal in guiding treatment decisions, potentially improving outcomes and quality of life for patients with myeloid malignancies. DNA Labs UAE, a reputable facility known for its advanced diagnostic services, ensures that the Oncomine Comprehensive Myeloid Panel Test is conducted with the highest standards of accuracy and reliability, offering patients and healthcare providers a crucial tool in the fight against myeloid cancers.
The “Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel Test” is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with Arthrogryposis and Congenital Myasthenic Syndrome (CMS). Arthrogryposis refers to a range of conditions characterized by joint contractures and muscle weakness present at birth, while CMS encompasses a group of genetic disorders that result in muscle fatigue and weakness due to impaired transmission of signals between nerves and muscles.
This gene panel test targets specific genes known to be linked to these conditions, facilitating an accurate diagnosis and enabling healthcare providers to tailor treatment plans effectively. Given the genetic complexity and variability of these disorders, the panel approach increases the likelihood of identifying the underlying genetic cause.
Priced at 8890 AED, the test represents a significant investment in pinpointing the genetic underpinnings of these conditions, offering hope for affected individuals and their families for better management and understanding of their health challenges. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, patients can expect a high level of accuracy and reliability in the test results, paving the way for improved outcomes.
The Ataxia Gene Panel Test, available at DNA Labs UAE for 7200 AED, is a comprehensive diagnostic tool designed to identify genetic mutations associated with various forms of ataxia. Ataxia, a neurological condition characterized by impaired balance, coordination, and speech, can be caused by mutations in multiple genes. This panel test examines a broad spectrum of genes simultaneously to pinpoint the specific genetic alterations responsible for the condition in an individual.
By leveraging advanced genetic sequencing technologies, the test offers a precise and efficient approach to diagnosing different types of hereditary ataxias. This is particularly valuable for individuals exhibiting ataxia symptoms, families with a history of the condition, or those seeking a definitive genetic explanation for neurological symptoms of unknown cause. The information obtained from the test can guide clinical management, inform prognosis, and assist in family planning decisions.
Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, clients are assured of accurate and reliable results. The cost of the test is set at 7200 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.
The Benign Infantile Epilepsy Gene Panel Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify specific genetic mutations associated with benign infantile epilepsy (BIE). This condition, typically emerging in the early months of a child’s life, is characterized by seizures that the child eventually outgrows, usually without long-term neurological effects. However, early and accurate diagnosis is crucial for effective management and to differentiate BIE from other more serious neurological conditions.
The test involves analyzing a small sample of the patient’s DNA, extracted from a blood sample, to scrutinize multiple genes known to be linked with benign infantile epilepsy. By employing cutting-edge genetic sequencing technologies, DNA Labs UAE ensures a comprehensive examination of these genes, facilitating a precise diagnosis.
The cost of the Benign Infantile Epilepsy Gene Panel Test at DNA Labs UAE is 7200 AED. This price reflects the advanced technology and expertise required to perform this intricate analysis. For families and physicians, the test offers invaluable insights, enabling tailored treatment plans that can significantly improve the quality of life for affected infants, ensuring they receive the most appropriate care from the earliest stages of their lives.
Bone Marrow Failure Syndrome Test at DNA Labs UAE
The Bone Marrow Failure Syndrome Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify various conditions that lead to the insufficient production of blood cells by the bone marrow. These conditions can be inherited or acquired, and early detection is crucial for effective management and treatment. The test examines genetic markers, blood cell counts, and bone marrow function to diagnose syndromes such as aplastic anemia, myelodysplastic syndromes, and others.
The test is priced at 7200 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed. Conducted in the state-of-the-art facilities of DNA Labs UAE, patients can expect accuracy, reliability, and confidentiality in their test results. This diagnostic tool is essential for individuals exhibiting symptoms of bone marrow failure or those with a family history of related conditions, guiding their clinical care with precise, personalized information.
